Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
FibroBiologics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | ||||||||||||||||
| Equity | Common stock, par value $0.00001 per share | Rule 457(c) | 4,343,220 | (2) | $ | 2.315 | (2) | $ | 10,054,554.30 | 153.10 per $1,000,000 | $ | 1,539.35 | ||||||||||||
| Equity | Common stock, par value $0.00001 per share, underlying convertible promissory notes | Rule 457(c) | 36,945,813 | (2) | $ | 2.315 | (2) | $ | 85,529,557.10 | 153.10 per $1,000,000 | $ | 13,094.58 | ||||||||||||
| Total Offering Amounts | $ | 95,584,111.40 | $ | 14,633.93 | ||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $ | 14,633.93 | ||||||||||||||||||||||
| (1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement on Form S-1 shall be deemed to cover any additional shares of common stock, par value $0.00001 per share, or the Common Stock, of FibroBiologics, Inc. that may be issued as a result of any stock dividend, stock split, recapitalization or other similar transaction, and any other securities with respect to which the outstanding shares are converted or exchanged. | |
| (2) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based on the average of the high and low sales price of Common Stock as reported on the Nasdaq Global Market on December 27, 2024. |